A recent medical study examining adverse event reports and health data from the U.S. Food and Drug Administration (FDA) has highlighted a rare association...
Promising results from Phase III clinical trials suggest that Upadacitinib, a drug currently approved for treating inflammatory conditions and arthritis, could emerge as an...
